PI-LAB-2025-067

Liraglutide, Independent Lab Report

Liraglutide 6mg · NextGen Peptides

Verified

Independent testing verdict Pass

This product matched its label.

Identity confirmed and measured purity of 97.3% met the stated ≥98% claim. Content measured 98.5% of label.

Identity verified
Yes

Mass spectrometry confirmed the labelled compound

Measured purity
97.3%

Label claimed ≥98%

Content accuracy
98.5%

5.91mg measured against 6mg claimed

Test recency
Older result

Published 17 months ago

Specimen PI-LAB-2025-067 Tested by Chelsea Analytical Group 17 samples tested from this company Purity & Testing score 91/100

Full laboratory evidence Findings table, methodology, chain of custody and the original report

Findings

Metric Label claim Measured Assessment
Purity (HPLC) ≥ 98% 97.3% Within analytical tolerance
Identity (MS) Liraglutide Confirmed Matches label
Content 6 mg 5.91 mg Within 5% of label

Methodology & chain of custody

Reversed-phase HPLC purity analysis with UV detection at 214nm.

The sample was purchased anonymously through standard retail checkout and shipped to an unaffiliated address, then logged, photographed, and forwarded under chain-of-custody documentation to Chelsea Analytical Group. See our full testing methodology.

Lot / batch
C5908-25
Purchased
Analysed
Published
Laboratory
Chelsea Analytical Group
Test type
Full panel (purity, identity, content, endotoxin)

Original laboratory report: PI-LAB-2025-067-report.pdf (document delivery arrives with the production storage backend)

More Tests, NextGen Peptides

PT-141
Purity 98.5% Verified
Retatrutide
Purity 99.7% Verified
Tirzepatide/Cagrilintide Blend
Purity 97.6% Verified

More Tests, Liraglutide

Liraglutide Quantum Peptide Group
Purity 97.6% Verified
Liraglutide Cardinal Metabolic Clinic
Purity 97.8% Verified
Liraglutide Helix Research Supply
Purity 97.7% Verified